BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15446553)

  • 1. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
    Yamaguchi U; Hasegawa T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pathology of soft tissue sarcomas].
    Schmidt D
    Radiologe; 1992 Dec; 32(12):579-83. PubMed ID: 1492148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of soft tissue sarcomas.
    Thway K
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):695-705. PubMed ID: 19734027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic evaluation of pediatric soft tissue tumors.
    Coffin CM; Dehner LP
    Am J Clin Pathol; 1998 Apr; 109(4 Suppl 1):S38-52. PubMed ID: 9533748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and staging for soft tissue sarcomas: an update.
    Jones NB; Iwenofu H; Scharschmidt T; Kraybill W
    Surg Oncol Clin N Am; 2012 Apr; 21(2):187-200. PubMed ID: 22365514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
    Hasegawa T
    Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current problems in clinico-morphological assessment of soft tissue tumors.
    Niezabitowski A
    Pol J Pathol; 2001; 52(1-2):7-14. PubMed ID: 11505683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material.
    Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA
    Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reproducibility of anatomo-pathological diagnoses: use of the kappa-test in histo-prognostic grading of soft tissue sarcomas in adults].
    Coindre JM; David M
    Bull Cancer; 1987; 74(1):75-81. PubMed ID: 3567389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT activation in soft tissue sarcomas.
    Tamborini E; Bonadiman L; Moiraghi L; Pilotti S; Pierotti MA
    Am J Clin Pathol; 2002 Sep; 118(3):472-3; author reply 473. PubMed ID: 12219791
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
    Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
    Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D; Beltrami G; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
    Rydholm A; Gustafson P; Alvegård TA; Saeter G; Blomqvist C
    Acta Orthop Scand Suppl; 1999 Jun; 285():50-7. PubMed ID: 10429623
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
    Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sarcomas of the bone and soft tissue: general observations].
    Marée D; Rouëssé J
    Bull Cancer; 1988; 75(5):409-15. PubMed ID: 3395705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.
    Mertens F; Strömberg U; Mandahl N; Dal Cin P; De Wever I; Fletcher CD; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van Den Berghe H; Vanni R; Willén H
    Cancer Res; 2002 Jul; 62(14):3980-4. PubMed ID: 12124330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.